Rep. Rosendale Responds to SCOTUS Ruling on Abortion Pill Mifepristone
June 13, 2024
June 13, 2024
WASHINGTON, June 13 -- Rep. Matt Rosendale, R-Montana, issued the following news release:
Today, Congressman Matt Rosendale (MT-02) released the following statement after the Supreme Court ruled in a unanimous decision that the Food and Drug Administration (FDA) can continue to ease access to the abortion pill mifepristone. Mifepristone was used in nearly two-thirds of all abortions in the U.S. last year.
"The disappointing ruling by the Supreme Court today allowed . . .
Today, Congressman Matt Rosendale (MT-02) released the following statement after the Supreme Court ruled in a unanimous decision that the Food and Drug Administration (FDA) can continue to ease access to the abortion pill mifepristone. Mifepristone was used in nearly two-thirds of all abortions in the U.S. last year.
"The disappointing ruling by the Supreme Court today allowed . . .